Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
- A. C. Tsai
- , C. Y. Wang
- , J. P. Liou
- , H. C. Pai
- , C. J. Hsiao
- , J. Y. Chang
- , J. C. Wang
- , C. M. Teng
- , S. L. Pan
Research output: Contribution to journal › Article › peer-review
19
Link opens in a new tab
Citations
(Scopus)